Aveanna Healthcare/$AVAH
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
- Ticker
- $AVAH
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 19,500
- Headquarters
- Atlanta, United States
- Website
- www.aveanna.com
AVAH Metrics
BasicAdvanced
$2.8B
10.59
$1.23
1.97
-
Price and volume
Market cap
$2.8B
Beta
1.97
52-week high
$14.71
52-week low
$5.93
Average daily volume
2.7M
Financial strength
Current ratio
1.162
Quick ratio
1.095
Long term debt to equity
4.551
Total debt to equity
5.227
Interest coverage (TTM)
2.24%
Profitability
EBITDA (TTM)
311.226
Gross margin (TTM)
32.04%
Net profit margin (TTM)
10.56%
Operating margin (TTM)
11.54%
Effective tax rate (TTM)
-78.29%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
9.68%
Return on equity (TTM)
198.57%
Valuation
Price to earnings (TTM)
10.594
Price to revenue (TTM)
1.067
Price to book
9.89
Price to tangible book (TTM)
-2.62
Price to free cash flow (TTM)
17.54
Free cash flow yield (TTM)
5.70%
Free cash flow per share (TTM)
0.745
Growth
Revenue change (TTM)
19.52%
Earnings per share change (TTM)
1,199.54%
3-year revenue growth (CAGR)
12.41%
3-year earnings per share growth (CAGR)
1.70%
What the Analysts think about AVAH
Analyst ratings (Buy, Hold, Sell) for Aveanna Healthcare stock.
Analyst projections of the future price of Aveanna Healthcare stock.
Bulls say / Bears say
Second-quarter revenue grew 13.7% year on year and adjusted EBITDA rose 8%. Aveanna raised its 2026 revenue outlook to above $2.68 billion and adjusted EBITDA outlook to above $365 million. (Aveanna Healthcare)
Home Health and Hospice revenue rose 14.8% in the second quarter, with care episodes up 18.5%. Management lifted the segment’s long-term organic growth target to 8%–10% from 5%–7%, giving Aveanna another growth engine beyond private duty care. (Home Health Care News)
California’s higher pediatric nursing rates are due to take effect in January 2027. If Aveanna can use them to attract more nurses, it could staff more authorised care and serve families who have so far faced limited capacity. (Home Health Care News)
Labour costs are outpacing revenue per hour in Private Duty Services: cost per hour rose 7.8% year on year, versus a 1.7% rise in revenue per hour. Overall gross margin fell to 32.6% from 35.8%, showing that growth is not yet translating into stronger gross profitability. (The Motley Fool)
Debt remains substantial: at quarter-end, Aveanna reported $1.32 billion of term loans and $165 million of securitisation borrowings, against $97.2 million of cash. The company used cash to fund its recent acquisition, leaving less liquidity to absorb setbacks or reduce debt quickly. (U.S. Securities and Exchange Commission)
Medicaid and Medicaid managed-care payments made up 80.5% of second-quarter revenue. That concentration leaves Aveanna exposed to changes in public funding and reimbursement rates, risks the company itself highlights in its latest filing. (U.S. Securities and Exchange Commission)
Data summarised monthly by Lightyear AI. Last updated on 13 Oct 2026.
AVAH Financial Performance
Revenues and expenses
AVAH Earnings Performance
Company profitability
Upcoming events
No upcoming events
AVAH News
AllArticlesVideos
Funds containing AVAH
Fund name | Fund size | $AVAH weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.03% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.03% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.02% |
Xtrackers MSCI World Small Cap$XSWC | $183M | 0.01% |
iShares MSCI World Small Cap€IUSN | $9B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.